Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05675410

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiati…

United States1,875 participantsStarted 2023-05-11

Treatment: Biospecimen Collection, Bleomycin Sulfate

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

All recent trials (1 shown)